Skip to main navigation Skip to search Skip to main content

Ameliorating adverse perinatal outcomes with Lactoferrin: An intriguing chemotherapeutic intervention

  • Julie A. Talbert
  • , Jacky Lu
  • , Sabrina K. Spicer
  • , Rebecca E. Moore
  • , Steven D. Townsend
  • , Jennifer A. Gaddy

Research output: Contribution to journal › Review article › peer-review

Abstract

Adverse pregnancy outcomes affect 54 million people globally per year, with at least 50% of these attributed to infection during gestation. These include inflammation of the membranes surrounding the growing fetus (chorioamnionitis), preterm prelabor rupture of membranes (PPROM), preterm birth (PTB), early-onset disease (EOD) and late-onset disease (LOD), neonatal and maternal sepsis, and maternal or fetal demise. Although universal screening and implementation of intrapartum antibiotic prophylaxis (IAP) has improved EOD outcomes, these interventions have not reduced the incidences of LOD or complications occurring early on during pregnancy such as PPROM and PTB. Thus, novel therapies are needed to prevent adverse pregnancy outcomes and to ameliorate disease risk in vulnerable populations. Lactoferrin has recently been explored as a potential therapeutic as it demonstrates strong antimicrobial and anti-biofilm activity. Lactoferrin is a glycoprotein capable of iron chelation found in a variety of human tissues and is produced in high concentrations in human breast milk. In recent studies, lactoferrin has shown promise inhibiting growth and biofilm formation of streptococcal species, including Group B Streptococcus (GBS), a prominent perinatal pathogen. Understanding the interactions between lactoferrin and GBS could elucidate a novel treatment strategy for adverse pregnancy outcomes caused by GBS infection.

Original languageEnglish (US)
Article number117037
JournalBioorganic and Medicinal Chemistry
Volume74
DOIs
StatePublished - Nov 15 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022 Elsevier Ltd

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antimicrobial
  • Infection
  • Lactoferrin
  • Pregnancy
  • Preterm birth

Fingerprint

Dive into the research topics of 'Ameliorating adverse perinatal outcomes with Lactoferrin: An intriguing chemotherapeutic intervention'. Together they form a unique fingerprint.

Cite this